Compass Pathways plc (NASDAQ: CMPS) announced it will release clinical data from two ongoing Phase 3 trials on February 17 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE